Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.
Nikolaou PE, Boengler K, Efentakis P, Vouvogiannopoulou K, Zoga A, Gaboriaud-Kolar N, Myrianthopoulos V, Alexakos P, Kostomitsopoulos N, Rerras I, Tsantili-Kakoulidou A, Skaltsounis AL, Papapetropoulos A, Iliodromitis EK, Schulz R, Andreadou I.
Nikolaou PE, et al. Among authors: boengler k.
Cardiovasc Res. 2019 Jun 1;115(7):1228-1243. doi: 10.1093/cvr/cvz061.
Cardiovasc Res. 2019.
PMID: 30843027